首页 > 最新文献

Urology Journal最新文献

英文 中文
A Step-by-Step Guide to Double-Puncture Technique for Endoscopic Management of Ureterocele. 输尿管膀胱内窥镜双穿刺技术分步指南》。
IF 1.5 4区 医学 Q3 Medicine Pub Date : 2024-06-09 DOI: 10.22037/uj.v16i7.6028
Behnam Nabavizadeh, Reza Nabavizadeh, Abdol-Mohammad Kajbafzadeh

To date, the optimal surgical technique for treatment of ureterocele remains unclear and the available options are variable. The endoscopic techniques that are gaining popularity mostly share major drawbacks including low success rate, high probability of mandatory secondary surgery and de novo vesicoureteral reflux to the ureterocele moiety. The Double-Puncture technique is shown to have promising outcomes in terms of long-term success and low rate of complications. In this video, a step-by-step guide to this technique is presented.

迄今为止,治疗输尿管积水的最佳手术技术仍不明确,可供选择的方案也多种多样。日渐流行的内窥镜技术大多都存在一些主要缺点,包括成功率低、必须进行二次手术的可能性高以及输尿管膀胱逆流至输尿管膀胱部位。双穿刺技术在长期成功率和低并发症发生率方面具有良好的效果。在本视频中,将逐步介绍这种技术。
{"title":"A Step-by-Step Guide to Double-Puncture Technique for Endoscopic Management of Ureterocele.","authors":"Behnam Nabavizadeh, Reza Nabavizadeh, Abdol-Mohammad Kajbafzadeh","doi":"10.22037/uj.v16i7.6028","DOIUrl":"10.22037/uj.v16i7.6028","url":null,"abstract":"<p><p>To date, the optimal surgical technique for treatment of ureterocele remains unclear and the available options are variable. The endoscopic techniques that are gaining popularity mostly share major drawbacks including low success rate, high probability of mandatory secondary surgery and de novo vesicoureteral reflux to the ureterocele moiety. The Double-Puncture technique is shown to have promising outcomes in terms of long-term success and low rate of complications. In this video, a step-by-step guide to this technique is presented.</p>","PeriodicalId":23416,"journal":{"name":"Urology Journal","volume":" ","pages":"273"},"PeriodicalIF":1.5,"publicationDate":"2024-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38471413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Insights beyond Established Norms: A Scoping Review of Genetic Testing for Infertile Men. 超越既定规范的新见解:不育男性基因检测范围审查》。
IF 1.5 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-06-09 DOI: 10.22037/uj.v20i.8008
Hamid Kalantari, Marjan Sabbaghian, Paraskevi Vogiatzi, Giovanni M Colpi, Mohammad Ali Sadighi Gilani

Purpose: From a diagnostic standpoint, certain approaches to genetic screening in clinical practice remain ambiguous in the era of assisted reproduction. Even the most current guidelines do not provide definite guidance on testing protocols, leaving clinicians to carefully determine which tests best serve patients struggling with infertility. The lack of uniformity in the current practice of male fertility evaluation can prove to be quite costly, thus necessitating healthcare practitioners to carefully appraise the necessity and weigh the advantages against potential economic and psychological detriments. The objective of this review is to map the existing literature on the general topic of the clinical indications of routine karyotyping and/or AZF screening in infertile men, identify key concepts, determine where the gaps are, and lastly, provide an overview of the conclusions drawn from a body of knowledge that varies widely in terms of methodologies or disciplines.

Materials and methods: A thorough search was conducted for the published findings up until July 2023, utilizing PubMed (MEDLINE). This comprehensive search involved the use of specific search keywords, either individually or in combination. The search terms employed were as follows: "Karyotype", "Klinefelter" or "KS" or "47,XXY", "AZF" or "Azoospermi*" and/or "microdeletion*" in the title or abstract. Once the titles and abstracts of selected articles were obtained, the complete texts of linked papers were meticulously scrutinized.

Results: A total of 191 records were identified from PubMed. During screening, 161 records (84.3%) were eliminated. Finally, 30 papers were included in this scoping review, which was conducted in 18 countries. The number of sequence tag sites (STSs) used in the studies varied from 5 to 59. The rate of AZF deletions among patients with NOA ranged from 1.3% to 53%. The mean frequency was estimated to be 5.6%. The rate of YCM among patients with XXY karyotype was nil in 19 out of 30 studies (63%), whilst, in the remaining studies, the rate varied from 0.8% to 67%.

Conclusion: This review provides insights into managing male infertility. The presence of spermatozoa in ejaculation and successful surgical retrieval cannot be excluded for individuals with AZFb/AZFbc microdeletions. Screening for Y chromosome microdeletions is not needed for mosaic or classic KS. Only 1% of individuals with sperm concentration exceeding 1×106 sperm/mL and less than 5×106 sperm/mL exhibit AZF microdeletions; therefore, testing referral for such populations may need reassessment. Individuals with mosaic monosomy X karyotype and certain chromosomal anomalies should be referred for AZF deletion screening. These findings have implications for male infertility management and future research.

目的:从诊断的角度来看,在辅助生殖时代,临床实践中的某些基因筛查方法仍然模糊不清。即使是最新的指南也没有为检测方案提供明确的指导,临床医生需要仔细确定哪种检测方法最适合不育症患者。 目前男性生育力评估的做法缺乏统一性,这可能会导致相当高的成本,因此医疗从业者必须仔细评估其必要性,并权衡其优势与潜在的经济和心理损害。本综述的目的是对不育男性常规核型和/或 AZF 筛查临床指征这一一般性主题的现有文献进行梳理,找出关键概念,确定存在的差距,最后概述从方法或学科差异较大的知识体系中得出的结论。材料与方法:利用 PubMed (MEDLINE),对截至 2023 年 7 月已发表的研究结果进行了全面搜索。这项综合搜索涉及使用特定的搜索关键词,可以单独使用,也可以组合使用。使用的检索词如下标题或摘要中的 "核型"、"Klinefelter "或 "KS "或 "47,XXY"、"AZF "或 "Azoospermi*"和/或 "微缺失*"。结果:从 PubMed 上共找到 191 条记录。在筛选过程中,161 条记录(84.3%)被剔除。最后,有 30 篇论文被纳入此次在 18 个国家进行的范围界定综述。研究中使用的序列标记位点(STS)数量从 5 个到 59 个不等。NOA患者的AZF缺失率从1.3%到53%不等。平均频率估计为 5.6%。在 30 项研究中,有 19 项(63%)研究发现 XXY 核型患者的 YCM 发生率为零,而在其余研究中,YCM 发生率从 0.8% 到 67% 不等。 结论:本综述为男性不育症的治疗提供了启示。不能排除AZFb/AZFbc微缺失患者在射精时出现精子并成功进行手术取精的可能性。镶嵌型或典型的 KS 不需要进行 Y 染色体微缺失筛查。精子浓度超过 1×106 个精子/毫升但低于 5×106 个精子/毫升的个体中,仅有 1%表现为 AZF 微缺失;因此,此类人群的检测转介可能需要重新评估。有镶嵌单体 X 核型和某些染色体异常的个体应转诊进行 AZF 缺失筛查。这些发现对男性不育症的治疗和未来研究具有重要意义。
{"title":"New Insights beyond Established Norms: A Scoping Review of Genetic Testing for Infertile Men.","authors":"Hamid Kalantari, Marjan Sabbaghian, Paraskevi Vogiatzi, Giovanni M Colpi, Mohammad Ali Sadighi Gilani","doi":"10.22037/uj.v20i.8008","DOIUrl":"10.22037/uj.v20i.8008","url":null,"abstract":"<p><strong>Purpose: </strong>From a diagnostic standpoint, certain approaches to genetic screening in clinical practice remain ambiguous in the era of assisted reproduction. Even the most current guidelines do not provide definite guidance on testing protocols, leaving clinicians to carefully determine which tests best serve patients struggling with infertility. The lack of uniformity in the current practice of male fertility evaluation can prove to be quite costly, thus necessitating healthcare practitioners to carefully appraise the necessity and weigh the advantages against potential economic and psychological detriments. The objective of this review is to map the existing literature on the general topic of the clinical indications of routine karyotyping and/or AZF screening in infertile men, identify key concepts, determine where the gaps are, and lastly, provide an overview of the conclusions drawn from a body of knowledge that varies widely in terms of methodologies or disciplines.</p><p><strong>Materials and methods: </strong>A thorough search was conducted for the published findings up until July 2023, utilizing PubMed (MEDLINE). This comprehensive search involved the use of specific search keywords, either individually or in combination. The search terms employed were as follows: \"Karyotype\", \"Klinefelter\" or \"KS\" or \"47,XXY\", \"AZF\" or \"Azoospermi*\" and/or \"microdeletion*\" in the title or abstract. Once the titles and abstracts of selected articles were obtained, the complete texts of linked papers were meticulously scrutinized.</p><p><strong>Results: </strong>A total of 191 records were identified from PubMed. During screening, 161 records (84.3%) were eliminated. Finally, 30 papers were included in this scoping review, which was conducted in 18 countries. The number of sequence tag sites (STSs) used in the studies varied from 5 to 59. The rate of AZF deletions among patients with NOA ranged from 1.3% to 53%. The mean frequency was estimated to be 5.6%. The rate of YCM among patients with XXY karyotype was nil in 19 out of 30 studies (63%), whilst, in the remaining studies, the rate varied from 0.8% to 67%.</p><p><strong>Conclusion: </strong>This review provides insights into managing male infertility. The presence of spermatozoa in ejaculation and successful surgical retrieval cannot be excluded for individuals with AZFb/AZFbc microdeletions. Screening for Y chromosome microdeletions is not needed for mosaic or classic KS. Only 1% of individuals with sperm concentration exceeding 1×106 sperm/mL and less than 5×106 sperm/mL exhibit AZF microdeletions; therefore, testing referral for such populations may need reassessment. Individuals with mosaic monosomy X karyotype and certain chromosomal anomalies should be referred for AZF deletion screening. These findings have implications for male infertility management and future research.</p>","PeriodicalId":23416,"journal":{"name":"Urology Journal","volume":" ","pages":"200-207"},"PeriodicalIF":1.5,"publicationDate":"2024-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140877452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Anterior Urethral Stricture: A Survey of Contemporary Practice of Iranian Urologists. 前尿道狭窄的处理:伊朗泌尿科医生的当代实践调查。
IF 1.5 4区 医学 Q3 Medicine Pub Date : 2024-06-09 DOI: 10.22037/uj.v20i.7886
Jalil Hosseini, Samin Khannejad, Armin Attar, Ali Goudarzikarim

Purpose: To evaluate Iranian urologists' approach to urethral stricture and assess how often they select open urethroplasty over minimally invasive procedures.

Material and methods: This cross-sectional observational study was conducted via www.

Survey: porsline.ir among members of the Iranian urologists' community. The urologists were contacted via email and social media applications (e.g., WhatsApp, Telegram), and data, including their demographic information and years of practice, as well as questions related to their attitude towards the management of urethral stricture, were collected.

Results: A total number of 376 patients were included in the current survey. The specialty of reconstructive urology was selected by less than 2% (n=5) as their field of interest. Only 6.64% (n=25) of the urologists stated that they received adequate training for management of urethral stricture. Only about 5% (n=19), believed that according to scientific resources, chose open urethroplasty as the initial management. Almost 94% (n=353) did not perform any urethroplasties during the past year and about 0.2% (n=2) performed more than 20 open urethroplasties. For diagnosing urethral stricture, almost 99% of them chose RUG+VCUG, 72% chose urethrocystoscopy, and 69% chose uroflowmetry in the third place. For evaluation of urethroplasty postoperative outcomes, 76% (n=269) used RUG+VCUG, 15% (n=56) used Rigid Cystoscopy, and 8% (n=29) used Flexible Cystoscopy, Conclusion: Iranian urologists prefer minimally invasive procedures for treating urethral stricture, similar to other countries. This lack of urologists' interest in open urethroplasty is greatly due to poor training during the residency years and little experience with urethral strictures. Therefore, further considerations in order to improve urologists' knowledge and expertise for management of urethral stricture is recommended.

目的:评估伊朗泌尿科医生治疗尿道狭窄的方法,并评估他们选择开放式尿道成形术而非微创手术的频率:这项横断面观察研究是通过 www.Survey: porsline.ir 在伊朗泌尿科医生社区成员中开展的。研究人员通过电子邮件和社交媒体应用程序(如 WhatsApp、Telegram)与泌尿科医生取得联系,并收集了包括他们的人口统计学信息和从业年限在内的数据,以及与他们对尿道狭窄治疗的态度有关的问题:共有 376 名患者参与了本次调查。只有不到 2%(n=5)的患者选择了重建泌尿外科专业作为其感兴趣的领域。只有 6.64%(n=25)的泌尿科医生表示,他们在治疗尿道狭窄方面接受过足够的培训。只有约 5%(n=19)的泌尿科医生认为,根据科学资源,他们会选择开放式尿道成形术作为初始治疗方法。近 94%(n=353)的医生在过去一年中没有做过任何尿道成形术,约 0.2%(n=2)的医生做过 20 多例开放式尿道成形术。在诊断尿道狭窄时,近 99% 的人选择 RUG+VCUG,72% 的人选择尿道膀胱镜检查,69% 的人选择尿流率测定,排在第三位。在评估尿道成形术术后效果时,76%(n=269)的人使用 RUG+VCUG,15%(n=56)的人使用硬性膀胱镜,8%(n=29)的人使用柔性膀胱镜:伊朗泌尿科医生更倾向于采用微创手术治疗尿道狭窄,这一点与其他国家相似。泌尿科医生对开放式尿道成形术缺乏兴趣,这在很大程度上是由于他们在住院医师培训期间接受的培训较差,以及对尿道狭窄缺乏经验。因此,建议进一步考虑提高泌尿科医生在尿道狭窄治疗方面的知识和专业技能。
{"title":"Management of Anterior Urethral Stricture: A Survey of Contemporary Practice of Iranian Urologists.","authors":"Jalil Hosseini, Samin Khannejad, Armin Attar, Ali Goudarzikarim","doi":"10.22037/uj.v20i.7886","DOIUrl":"10.22037/uj.v20i.7886","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate Iranian urologists' approach to urethral stricture and assess how often they select open urethroplasty over minimally invasive procedures.</p><p><strong>Material and methods: </strong>This cross-sectional observational study was conducted via www.</p><p><strong>Survey: </strong>porsline.ir among members of the Iranian urologists' community. The urologists were contacted via email and social media applications (e.g., WhatsApp, Telegram), and data, including their demographic information and years of practice, as well as questions related to their attitude towards the management of urethral stricture, were collected.</p><p><strong>Results: </strong>A total number of 376 patients were included in the current survey. The specialty of reconstructive urology was selected by less than 2% (n=5) as their field of interest. Only 6.64% (n=25) of the urologists stated that they received adequate training for management of urethral stricture. Only about 5% (n=19), believed that according to scientific resources, chose open urethroplasty as the initial management. Almost 94% (n=353) did not perform any urethroplasties during the past year and about 0.2% (n=2) performed more than 20 open urethroplasties. For diagnosing urethral stricture, almost 99% of them chose RUG+VCUG, 72% chose urethrocystoscopy, and 69% chose uroflowmetry in the third place. For evaluation of urethroplasty postoperative outcomes, 76% (n=269) used RUG+VCUG, 15% (n=56) used Rigid Cystoscopy, and 8% (n=29) used Flexible Cystoscopy, Conclusion: Iranian urologists prefer minimally invasive procedures for treating urethral stricture, similar to other countries. This lack of urologists' interest in open urethroplasty is greatly due to poor training during the residency years and little experience with urethral strictures. Therefore, further considerations in order to improve urologists' knowledge and expertise for management of urethral stricture is recommended.</p>","PeriodicalId":23416,"journal":{"name":"Urology Journal","volume":" ","pages":"269-270"},"PeriodicalIF":1.5,"publicationDate":"2024-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140140791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perioperative Outcomes of Open Extra-peritoneal Versus Laparoscopic Radical Cystoprostatectomy: A single Center Comparative Study. 开腹腹膜外与腹腔镜根治性前列腺囊肿切除术的围手术期疗效:单中心比较研究
IF 1.5 4区 医学 Q3 Medicine Pub Date : 2024-05-06 DOI: 10.22037/uj.v21i03.7937
Cengiz Çanakcı, Orkunt Özkaptan, Erdinç Dinçer, Osman Murat Ipek, Gürkan Dalgıç, Ahmet Sahan

Purpose: To compare 90-day  perioperative complications and pathological outcomes between laparoscopic radical cystectomy (LRC) and extraperitoneal radical cystectomy (EORC) approaches.

Materials and methods: All operations were performed in a single high-volume tertiary referee center by the same surgical team.Males ≥ 18 years with pre-cystectomy clinical T1-T3 disease and having undergone an ileal conduit were included. Exclusion criteria included patients with inflammatory bowel disease, previous pelvic and/or abdominal irradiation, neo-adjuvant chemotherapy, and/or clinical T4 disease. Perioperative outcomes such as operative time, estimated blood loss, transfusion rate, hospital stay, and 90-day complications were evaluated. The recovery duration of regular bowel activity, mean stool passage,and ileus rates were recorded.

Results: A total of 221 patients met the inclusion criteria(81 LRC and 130 EORC). Demographics and preoperative parameters were comparable. Intraoperative estimated blood lossfavored LRC by a median of 450 mL (200-900) P=.021) vs. a median of 700 mL (300-2900) for EORC. The transfusion rate did not differ between the two groups; %14.8 (N=12) for the LRC and %20.8 (N=27) for EORC (P=.37). The median hospital stay was 9 (4-49) days for EORC and 8 (4-29) days for LRC (P=.011). The need for analgesics to control pain through an epidural catheter was higher for EORC (P=.042). There was no difference in overall complication rates (P=.47).

Conclusion:   Although LRC appears to have a slight advantage over EORC, both techniques yield satisfactory results in regard to ileus rates and 90-day perioperative complications.

目的:比较腹腔镜根治性膀胱切除术(LRC)和腹膜外根治性膀胱切除术(EORC)两种方法的90天围手术期并发症和病理结果:所有手术均由同一外科团队在一家高容量三级裁判中心进行。年龄≥18岁的男性患者均在切除术前患有临床T1-T3疾病,并接受过回肠导管手术。排除标准包括患有炎症性肠病、曾接受盆腔和/或腹部照射、新辅助化疗和/或临床T4疾病的患者。对手术时间、估计失血量、输血率、住院时间和 90 天并发症等围术期结果进行了评估。此外,还记录了正常排便活动的恢复时间、平均粪便通过率和回肠率:共有 221 例患者符合纳入标准(81 例 LRC 和 130 例 EORC)。人口统计学和术前参数具有可比性。术中估计失血量中位数为 450 毫升(200-900),LRC 更优,而 EORC 中位数为 700 毫升(300-2900)。两组的输血率没有差异:LRC 为 14.8%(12 例),EORC 为 20.8%(27 例)(P=.37)。EORC 的中位住院时间为 9(4-49)天,LRC 为 8(4-29)天(P=0.011)。EORC患者通过硬膜外导管止痛的需求更高(P=.042)。总体并发症发生率没有差异(P=.47):虽然 LRC 似乎比 EORC 略胜一筹,但在回肠率和 90 天围手术期并发症方面,两种技术都取得了令人满意的结果。
{"title":"Perioperative Outcomes of Open Extra-peritoneal Versus Laparoscopic Radical Cystoprostatectomy: A single Center Comparative Study.","authors":"Cengiz Çanakcı, Orkunt Özkaptan, Erdinç Dinçer, Osman Murat Ipek, Gürkan Dalgıç, Ahmet Sahan","doi":"10.22037/uj.v21i03.7937","DOIUrl":"10.22037/uj.v21i03.7937","url":null,"abstract":"<p><strong>Purpose: </strong>To compare 90-day  perioperative complications and pathological outcomes between laparoscopic radical cystectomy (LRC) and extraperitoneal radical cystectomy (EORC) approaches.</p><p><strong>Materials and methods: </strong>All operations were performed in a single high-volume tertiary referee center by the same surgical team.Males ≥ 18 years with pre-cystectomy clinical T1-T3 disease and having undergone an ileal conduit were included. Exclusion criteria included patients with inflammatory bowel disease, previous pelvic and/or abdominal irradiation, neo-adjuvant chemotherapy, and/or clinical T4 disease. Perioperative outcomes such as operative time, estimated blood loss, transfusion rate, hospital stay, and 90-day complications were evaluated. The recovery duration of regular bowel activity, mean stool passage,and ileus rates were recorded.</p><p><strong>Results: </strong>A total of 221 patients met the inclusion criteria(81 LRC and 130 EORC). Demographics and preoperative parameters were comparable. Intraoperative estimated blood lossfavored LRC by a median of 450 mL (200-900) P=.021) vs. a median of 700 mL (300-2900) for EORC. The transfusion rate did not differ between the two groups; %14.8 (N=12) for the LRC and %20.8 (N=27) for EORC (P=.37). The median hospital stay was 9 (4-49) days for EORC and 8 (4-29) days for LRC (P=.011). The need for analgesics to control pain through an epidural catheter was higher for EORC (P=.042). There was no difference in overall complication rates (P=.47).</p><p><strong>Conclusion: </strong>  Although LRC appears to have a slight advantage over EORC, both techniques yield satisfactory results in regard to ileus rates and 90-day perioperative complications.</p>","PeriodicalId":23416,"journal":{"name":"Urology Journal","volume":" ","pages":"175-181"},"PeriodicalIF":1.5,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140855244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Performance of the EORTC and CUETO Models to Predict Recurrence and Progression in High-risk Non-muscle-invasive Bladder Cancer Patients. 预测高风险非肌层浸润性膀胱癌患者复发和病情进展的 EORTC 和 CUETO 模型的性能。
IF 1.5 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2024-05-06 DOI: 10.22037/uj.v20i.7854
Yaşar Pazır, Abdullah Esmeray, Mucahit Gelmis, Ufuk Caglar, Faruk Ozgor, Omer Sarılar, Fatih Akbulut

Purpose: To evaluate the performance of the European Organization for Research and Treatment of Cancer (EORTC) and the Spanish Urological Club for Oncological Treatment (CUETO) risk scoring models in non-muscle-invasive bladder cancer (NMIBC) patients defined as high risk according to European Association of Urology guidelines and managed based on current recommendations.

Material and methods: Data from 187 high-risk NMIBC patients treated at a tertiary center between July 2010 and November 2021 were analyzed retrospectively. One- and five-year recurrence- and progression-free survival were assessed for each patient using the EORTC and CUETO risk scores. The patients were divided into four risk groups according to their risk scores as low, medium-low, medium-high and high risk, as indicated in the models. Discriminative ability was evaluated with the Harrell's concordance index (c-index).

Results: Both risk scoring models overestimated the risk of recurrence and progression at one and five years. Only the prediction of recurrence at five years in the high risk group according to the CUETO model was compatible with our cohort. CUETO (c-indices for recurrence and progression were 0.802 and 0.834, respectively) exhibited better discrimination than EORTC (0.722 for recurrence and 0.752 for progression) in the prediction of disease recurrence and progression.

Conclusion: The CUETO model was superior to the EORTC model in predicting recurrence and progression and stratifying patients with different prognoses in our high-risk NMIBC patient population treated according to current guideline recommendations. However, both models overestimated the probability of disease recurrence and progression. Only the probability of recurrence at five years in the high-risk group of the CUETO model was compatible with our cohort.

目的:评估欧洲癌症研究与治疗组织(EORTC)和西班牙肿瘤治疗泌尿学俱乐部(CUETO)风险评分模型在根据欧洲泌尿学协会指南被定义为高风险的非肌层浸润性膀胱癌(NMIBC)患者中的表现,并根据现行建议进行管理:对2010年7月至2021年11月期间在一家三级中心接受治疗的187名高风险NMIBC患者的数据进行了回顾性分析。采用 EORTC 和 CUETO 风险评分对每位患者的一年和五年无复发和无进展生存期进行了评估。如模型所示,根据风险评分将患者分为低风险、中低风险、中高风险和高风险四个风险组。用哈雷尔一致性指数(c-index)评估判别能力:结果:两种风险评分模型都高估了一年和五年后复发和病情恶化的风险。只有 CUETO 模型对高风险组五年后复发的预测与我们的队列相符。在预测疾病复发和进展方面,CUETO(复发和进展的c指数分别为0.802和0.834)比EORTC(复发和进展的c指数分别为0.722和0.752)具有更好的区分度:结论:CUETO 模型在预测高危 NMIBC 患者的复发和进展以及对不同预后的患者进行分层方面优于 EORTC 模型。然而,两种模型都高估了疾病复发和进展的概率。只有 CUETO 模型中高风险组的五年复发概率与我们的队列相符。
{"title":"Performance of the EORTC and CUETO Models to Predict Recurrence and Progression in High-risk Non-muscle-invasive Bladder Cancer Patients.","authors":"Yaşar Pazır, Abdullah Esmeray, Mucahit Gelmis, Ufuk Caglar, Faruk Ozgor, Omer Sarılar, Fatih Akbulut","doi":"10.22037/uj.v20i.7854","DOIUrl":"10.22037/uj.v20i.7854","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the performance of the European Organization for Research and Treatment of Cancer (EORTC) and the Spanish Urological Club for Oncological Treatment (CUETO) risk scoring models in non-muscle-invasive bladder cancer (NMIBC) patients defined as high risk according to European Association of Urology guidelines and managed based on current recommendations.</p><p><strong>Material and methods: </strong>Data from 187 high-risk NMIBC patients treated at a tertiary center between July 2010 and November 2021 were analyzed retrospectively. One- and five-year recurrence- and progression-free survival were assessed for each patient using the EORTC and CUETO risk scores. The patients were divided into four risk groups according to their risk scores as low, medium-low, medium-high and high risk, as indicated in the models. Discriminative ability was evaluated with the Harrell's concordance index (c-index).</p><p><strong>Results: </strong>Both risk scoring models overestimated the risk of recurrence and progression at one and five years. Only the prediction of recurrence at five years in the high risk group according to the CUETO model was compatible with our cohort. CUETO (c-indices for recurrence and progression were 0.802 and 0.834, respectively) exhibited better discrimination than EORTC (0.722 for recurrence and 0.752 for progression) in the prediction of disease recurrence and progression.</p><p><strong>Conclusion: </strong>The CUETO model was superior to the EORTC model in predicting recurrence and progression and stratifying patients with different prognoses in our high-risk NMIBC patient population treated according to current guideline recommendations. However, both models overestimated the probability of disease recurrence and progression. Only the probability of recurrence at five years in the high-risk group of the CUETO model was compatible with our cohort.</p>","PeriodicalId":23416,"journal":{"name":"Urology Journal","volume":" ","pages":"169-174"},"PeriodicalIF":1.5,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140140792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Necessity of Incorporating an Interposition Flap During Vesicovaginal Fistula Repair: Can Modifying the Method of Vaginal Repair Serve as a Substitute? A Randomized Clinical Trial. 在膀胱阴道瘘修补术中加入间置瓣的必要性:改变阴道修补方法能否起到替代作用?随机临床试验_单盲。
IF 1.5 4区 医学 Q3 Medicine Pub Date : 2024-05-06 DOI: 10.22037/uj.v20i.7950
Mohammad Hatef Khorami, Mahtab Zargham, Pegah Taheri, Farshad Gholipoor, Maede Safari

Purpose: Traditionally, an omental flap is employed to reduce the risk of recurrence of vesicovaginal fistula (VVF) repair. In this study, we employed a modified surgical technique wherein the vaginal defect was closed using Connell sutures, without incorporation of an omental flap, aiming to mitigate potential complications.

Material and method: Between 2010 to 2018, the current randomized clinical trial was conducted on 52 women who were candidates for open fistula repair. The patients were randomly allocated into two groups. In one group, the conventional method of fistula repair was performed involving an omental flap, while in the other group, we used a modified approach with a variation in the vaginal wall closure technique. In-hospital variables, including the length of surgery, hospital stay, and occurrences of ileus, were recorded. Patient follow-up extended for one year, with assessments conducted one, six, and twelve months postoperatively. These evaluations encompassed pad test to ascertain success rates and identify any potential complications.

Results: The final analysis comprised 49 patients, with an average age of 46.5 years. Baseline characteristics were comparable between the two groups (P-values > 0.05). The modified technique was associated with significantly reduced surgical duration (P = ˂ 0.001), and shorter hospital stays (P < 0.001). Ileus occurrence was reduced, but it was not significant(P = 0.856). However, the success rate showed no significant difference between the groups, with a success rate of 100% for the modified technique compared to 91.6% for the classic O'Conner method (P = 0.288).

Conclusion: Based on the findings of this study, vaginal wall closure using Connell sutures during VVF repair demonstrates a success rate equivalent to the classic approach involving an omental flap. Moreover, this technique presents a reduced incidence of adverse effects, along with decreased surgical duration, hospital stay, and postoperative ileus.

目的:传统上,膀胱阴道瘘(VVF)修复术采用网膜瓣以降低复发风险。在本研究中,我们采用了一种改良的手术技术,即使用 Connell 缝线缝合阴道缺损,而不使用网膜瓣,旨在减少潜在的并发症:2010年至2018年期间,我们对52名肛瘘开放性修补术候选患者进行了随机临床试验。患者被随机分为两组。其中一组采用传统的网膜瓣瘘管修补术,另一组则采用改良的阴道壁闭合技术。我们记录了院内变量,包括手术时间、住院时间和回肠瘘发生率。对患者进行了为期一年的随访,并在术后 1 个月、6 个月和 12 个月进行了评估。这些评估包括PAD测试,以确定成功率和潜在并发症:最终分析包括 49 名患者,平均年龄为 46.5 岁。两组患者的基线特征相当(P 值大于 0.05)。改良技术明显缩短了手术时间(P=˂0.001),缩短了住院时间(P=˂0.001):根据这项研究的结果,在 VVF 修复术中使用 Connell 缝线缝合阴道壁的成功率与使用网膜瓣的传统方法相当。此外,该技术还降低了不良反应的发生率,缩短了手术时间、缩短了住院时间、减少了术后回肠梗阻。
{"title":"The Necessity of Incorporating an Interposition Flap During Vesicovaginal Fistula Repair: Can Modifying the Method of Vaginal Repair Serve as a Substitute? A Randomized Clinical Trial.","authors":"Mohammad Hatef Khorami, Mahtab Zargham, Pegah Taheri, Farshad Gholipoor, Maede Safari","doi":"10.22037/uj.v20i.7950","DOIUrl":"10.22037/uj.v20i.7950","url":null,"abstract":"<p><strong>Purpose: </strong>Traditionally, an omental flap is employed to reduce the risk of recurrence of vesicovaginal fistula (VVF) repair. In this study, we employed a modified surgical technique wherein the vaginal defect was closed using Connell sutures, without incorporation of an omental flap, aiming to mitigate potential complications.</p><p><strong>Material and method: </strong>Between 2010 to 2018, the current randomized clinical trial was conducted on 52 women who were candidates for open fistula repair. The patients were randomly allocated into two groups. In one group, the conventional method of fistula repair was performed involving an omental flap, while in the other group, we used a modified approach with a variation in the vaginal wall closure technique. In-hospital variables, including the length of surgery, hospital stay, and occurrences of ileus, were recorded. Patient follow-up extended for one year, with assessments conducted one, six, and twelve months postoperatively. These evaluations encompassed pad test to ascertain success rates and identify any potential complications.</p><p><strong>Results: </strong>The final analysis comprised 49 patients, with an average age of 46.5 years. Baseline characteristics were comparable between the two groups (P-values > 0.05). The modified technique was associated with significantly reduced surgical duration (P = ˂ 0.001), and shorter hospital stays (P < 0.001). Ileus occurrence was reduced, but it was not significant(P = 0.856). However, the success rate showed no significant difference between the groups, with a success rate of 100% for the modified technique compared to 91.6% for the classic O'Conner method (P = 0.288).</p><p><strong>Conclusion: </strong>Based on the findings of this study, vaginal wall closure using Connell sutures during VVF repair demonstrates a success rate equivalent to the classic approach involving an omental flap. Moreover, this technique presents a reduced incidence of adverse effects, along with decreased surgical duration, hospital stay, and postoperative ileus.</p>","PeriodicalId":23416,"journal":{"name":"Urology Journal","volume":" ","pages":"189-194"},"PeriodicalIF":1.5,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139698360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic Value of GSTP1, RASSF1, AND RASSF2 Methylation in Serum of Prostate Cancer Patients. 前列腺癌患者血清中 GSTP1、RASSF1 和 RASSF2 甲基化的诊断价值
IF 1.5 4区 医学 Q3 Medicine Pub Date : 2024-05-06 DOI: 10.22037/uj.v20i.8014
Emre Aykanli, Serdar Arisan, Elif Damla Arisan, Abdullah Hizir Yavuzsan

Purpose: Considering the inadequacy of PSA measurement in the diagnosis of prostate cancer, it is aimed to establish a potential liquid biopsy diagnostic panel.

Materials and methods: 39 patients who underwent TRUS-biopsy and 15 healthy volunteers were included. Approximately 15 ml of venous blood samples taken from healthy volunteers and patients before biopsy were separated as plasma. Hypermethylation status of GSTP1 and RASSF1:RASSF2 genes was revealed in cfDNA materials collected from plasma samples. Correlation of this epigenetic change detected in PCa, BPH and healthy volunteer groups with pathology results was examined.

Results: Pathology reports of 39 patients included were 13 PCa, 3 ASAP, 3 HGPIN, and 20 BPH. In total, 3 of the patients with PCa had positive GSTP1, 4 had RASSF1 and 9 had positive RASSF2 methylation. It was seen that RASSF2 had the highest sensitivity (69%), specificity (39%) and NPV (80%), while RASSF1 had the highest PPV (30%). When the binary combinations of genes were examined it was observed that the GSTP1:RASSF1 combination had the highest sensitivity (46%), specificity (76%) and NPV (82%). When the methylation of all three genes was examined, it was observed that the sensitivity was quite low (8%), but the specificity (83%) increased significantly.

Conclusion: Although we observed that the GSTP1 and RASSF1 methylation positivity rates that we examined in our study were higher in patients without prostate cancer, we found that the RASSF2 methylation rate was higher in patients with prostate cancer. randomized controlled studies are needed.

目的:考虑到 PSA 测量在前列腺癌诊断中的不足,我们旨在建立一个潜在的液体活检诊断面板。材料:纳入 39 名接受 TRUS 活检的患者和 15 名健康志愿者,活检前从健康志愿者和患者身上采集约 15 毫升静脉血样本,分离为血浆。从血浆样本中收集的 cfDNA 材料显示了 GSTP1 和 RASSF1:RASSF2 基因的高甲基化状态。研究了在 PCa、良性前列腺增生症和健康志愿者组中检测到的这种表观遗传学变化与病理学结果的相关性:39 名患者的病理报告包括 13 例 PCa、3 例 ASAP、3 例 HGPIN 和 20 例良性前列腺增生。其中,3 名 PCa 患者的 GSTP1 呈阳性,4 名患者的 RASSF1 呈阳性,9 名患者的 RASSF2 甲基化呈阳性。结果显示,RASSF2 的灵敏度(69%)、特异性(39%)和 NPV(80%)最高,而 RASSF1 的 PPV(30%)最高。在检测基因的二元组合时,发现 GSTP1:RASSF1 组合的灵敏度(46%)、特异性(76%)和 NPV(82%)最高。当检测所有三个基因的甲基化时,发现灵敏度相当低(8%),但特异性(83%)显著增加: 结论:尽管我们在研究中观察到 GSTP1 和 RASSF1 甲基化阳性率在非前列腺癌患者中更高,但我们发现 RASSF2 甲基化率在前列腺癌患者中更高。
{"title":"Diagnostic Value of GSTP1, RASSF1, AND RASSF2 Methylation in Serum of Prostate Cancer Patients.","authors":"Emre Aykanli, Serdar Arisan, Elif Damla Arisan, Abdullah Hizir Yavuzsan","doi":"10.22037/uj.v20i.8014","DOIUrl":"10.22037/uj.v20i.8014","url":null,"abstract":"<p><strong>Purpose: </strong>Considering the inadequacy of PSA measurement in the diagnosis of prostate cancer, it is aimed to establish a potential liquid biopsy diagnostic panel.</p><p><strong>Materials and methods: </strong>39 patients who underwent TRUS-biopsy and 15 healthy volunteers were included. Approximately 15 ml of venous blood samples taken from healthy volunteers and patients before biopsy were separated as plasma. Hypermethylation status of GSTP1 and RASSF1:RASSF2 genes was revealed in cfDNA materials collected from plasma samples. Correlation of this epigenetic change detected in PCa, BPH and healthy volunteer groups with pathology results was examined.</p><p><strong>Results: </strong>Pathology reports of 39 patients included were 13 PCa, 3 ASAP, 3 HGPIN, and 20 BPH. In total, 3 of the patients with PCa had positive GSTP1, 4 had RASSF1 and 9 had positive RASSF2 methylation. It was seen that RASSF2 had the highest sensitivity (69%), specificity (39%) and NPV (80%), while RASSF1 had the highest PPV (30%). When the binary combinations of genes were examined it was observed that the GSTP1:RASSF1 combination had the highest sensitivity (46%), specificity (76%) and NPV (82%). When the methylation of all three genes was examined, it was observed that the sensitivity was quite low (8%), but the specificity (83%) increased significantly.</p><p><strong>Conclusion: </strong>Although we observed that the GSTP1 and RASSF1 methylation positivity rates that we examined in our study were higher in patients without prostate cancer, we found that the RASSF2 methylation rate was higher in patients with prostate cancer. randomized controlled studies are needed.</p>","PeriodicalId":23416,"journal":{"name":"Urology Journal","volume":" ","pages":"182-188"},"PeriodicalIF":1.5,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140140790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic Obstructive Pulmonary Disease Mortality in Bladder Cancer Patients: A SEER-Based Competing Risk Analysis. 膀胱癌症患者慢性阻塞性肺病死亡率:基于SEER的竞争风险分析。
IF 1.5 4区 医学 Q3 Medicine Pub Date : 2024-05-06 DOI: 10.22037/uj.v20i.7644
Shunde Wang, Chengguo Ge

Purpose: This study was designed to evaluate risk of mortality from chronic obstructive pulmonary disease (COPD) in patients with bladder cancer (BC).

Methods and materials: Data on patients diagnosed with BC by pathology between 2000 and 2016 were collected from the Surveillance, Epidemiology, and End Results (SEER) database. Based on reference data from the general population, the standardized mortality rate (SMR) is calculated. Nelson-Aalen cumulative hazard curves were used for assessment of the risk of COPD mortality in BC patients. Multivariable competing risk models were conducted. The proportional hazards assumption was tested using Schoenfeld residuals, which were scaled and plotted over time for each risk factor.

Results: A total of 237,563 BC patients were identified for further analysis from the SEER database, 5,198 of these patients experienced COPD mortality; the overall SMR for COPD mortality in BC patients was 1.58 (95% CI: 1.54-1.63). Age, race, year of diagnosis, histologic type, summary stage, surgery, marital status, college education level, and median household income independently predicted COPD mortality in BC patients.

Conclusions: In comparison to the general population, the risk of COPD mortality is significantly higher in patients with BC. Pre-identification of high-risk groups and respiratory care provisions are important measures to effectively improve survival in this group of patients.

目的:本研究旨在评估慢性阻塞性肺病(COPD)患者死于膀胱癌症(BC)的风险。方法和材料:从监测、流行病学和最终结果(SEER)数据库收集2000年至2016年经病理诊断为慢性阻塞性肺疾病(BC)患者的数据。根据普通人群的参考数据,计算标准化死亡率(SMR)。Nelson-Aalen累积危险曲线用于评估BC患者COPD死亡率的风险。进行了多变量竞争风险模型。比例风险假设使用舍恩菲尔德残差进行了测试,该残差随时间对每个风险因素进行了缩放和绘制。结果:SEER数据库中共确定237563名BC患者进行进一步分析,其中5198名患者出现COPD死亡率;BC患者COPD死亡率的总体SMR为1.58(95%CI:1.54-1.63)。年龄、种族、诊断年份、组织学类型、总结阶段、手术、婚姻状况、大学教育水平和家庭收入中位数独立预测BC患者的COPD死亡率。结论:与普通人群相比,慢性阻塞性肺病患者的死亡率明显更高。预先识别高危人群和提供呼吸护理是有效提高这类患者生存率的重要措施。
{"title":"Chronic Obstructive Pulmonary Disease Mortality in Bladder Cancer Patients: A SEER-Based Competing Risk Analysis.","authors":"Shunde Wang, Chengguo Ge","doi":"10.22037/uj.v20i.7644","DOIUrl":"10.22037/uj.v20i.7644","url":null,"abstract":"<p><strong>Purpose: </strong>This study was designed to evaluate risk of mortality from chronic obstructive pulmonary disease (COPD) in patients with bladder cancer (BC).</p><p><strong>Methods and materials: </strong>Data on patients diagnosed with BC by pathology between 2000 and 2016 were collected from the Surveillance, Epidemiology, and End Results (SEER) database. Based on reference data from the general population, the standardized mortality rate (SMR) is calculated. Nelson-Aalen cumulative hazard curves were used for assessment of the risk of COPD mortality in BC patients. Multivariable competing risk models were conducted. The proportional hazards assumption was tested using Schoenfeld residuals, which were scaled and plotted over time for each risk factor.</p><p><strong>Results: </strong>A total of 237,563 BC patients were identified for further analysis from the SEER database, 5,198 of these patients experienced COPD mortality; the overall SMR for COPD mortality in BC patients was 1.58 (95% CI: 1.54-1.63). Age, race, year of diagnosis, histologic type, summary stage, surgery, marital status, college education level, and median household income independently predicted COPD mortality in BC patients.</p><p><strong>Conclusions: </strong>In comparison to the general population, the risk of COPD mortality is significantly higher in patients with BC. Pre-identification of high-risk groups and respiratory care provisions are important measures to effectively improve survival in this group of patients.</p>","PeriodicalId":23416,"journal":{"name":"Urology Journal","volume":" ","pages":"146-154"},"PeriodicalIF":1.5,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41171467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive Analysis of Perioperative Factors Influencing the Risk of Biochemical Recurrence in Patients with Radical Prostatectomy. 全面分析影响根治性前列腺切除术患者生化复发风险的围手术期因素
IF 1.5 4区 医学 Q3 Medicine Pub Date : 2024-05-06 DOI: 10.22037/uj.v20i.7835
Mihnea Bogdan Borz, Vlad Horia Schitcu, Nicolae Crisan, Bogdan Petrut, Oliviu Cristian Borz, Paul Cristian Borz, Igor Duquesne, Jordan Nasri, Ioan Coman

Purpose: To analyze the perioperative factors that influence the risk of biochemical recurrence (BCR) in patients with localized PCa undergoing radical prostatectomy Materials and Methods: A total of 457 patients, operated by 2 surgeons in our high-volume oncological center were included in the initial database. Patients who underwent RP for clinically localized PCa in our clinic from 2016 to 2021 were included in the study. Perioperative data were retrospectively reviewed for this study. Follow-up data including post-operative PSA and adjuvant treatment was prospectively gathered by contacting the patients or from the follow-up consultation. Final database was composed of 366 patients who underwent open or 3D laparoscopic RP. Statistical analysis was performed to emphasize the most powerful parameters that influence the BCR.  Results: Accounting for multivariable analysis, 4 parameters were statistically significant: initial PSA (iPSA), Gleason score, vascular involvement and positive surgical margins. For the group of patients with no positive margins, 3 parameters were statistically significant: iPSA above 10,98 ng/mL (AUC=0,71); lymph node involvement and Gleason score. Multivariable Cox regression showed that positive margins and iPSA had a significant impact on the time to BCR. Patients that received adjuvant therapy were excluded from the study. Out of the whole cohort, 27,3% of patients presented BCR.

Conclusion: Perioperative factors need to be carefully analyzed and a detailed follow-up needs to be conducted in order to assess the risk of biochemical recurrence, resulting in the optimal time for adjuvant treatment implementation.

目的:分析影响接受根治性前列腺切除术的局部 PCa 患者生化复发(BCR)风险的围手术期因素:初始数据库共收录了457名患者,这些患者均由本院高容量肿瘤中心的两名外科医生进行了手术。研究纳入了 2016 年至 2021 年期间在本诊所接受前列腺癌根治术的临床局部 PCa 患者。本研究对围手术期数据进行了回顾性审查。包括术后 PSA 和辅助治疗在内的随访数据则通过与患者联系或随访咨询进行前瞻性收集。最终数据库由366名接受开腹或3D腹腔镜RP手术的患者组成。统计分析强调了对 BCR 影响最大的参数。 结果显示在多变量分析中,4个参数具有统计学意义:初始PSA(iPSA)、Gleason评分、血管受累和手术切缘阳性。在无手术切缘阳性的患者组中,有 3 个参数具有统计学意义:iPSA 超过 10.98 纳克/毫升(AUC=0.71);淋巴结受累和 Gleason 评分。多变量 Cox 回归显示,边缘阳性和 iPSA 对 BCR 的时间有显著影响。本研究排除了接受辅助治疗的患者。在所有患者中,27.3%的患者出现了BCR:结论:需要仔细分析围手术期的因素,并进行详细的随访,以评估生化复发的风险,从而确定实施辅助治疗的最佳时间。
{"title":"Comprehensive Analysis of Perioperative Factors Influencing the Risk of Biochemical Recurrence in Patients with Radical Prostatectomy.","authors":"Mihnea Bogdan Borz, Vlad Horia Schitcu, Nicolae Crisan, Bogdan Petrut, Oliviu Cristian Borz, Paul Cristian Borz, Igor Duquesne, Jordan Nasri, Ioan Coman","doi":"10.22037/uj.v20i.7835","DOIUrl":"10.22037/uj.v20i.7835","url":null,"abstract":"<p><strong>Purpose: </strong>To analyze the perioperative factors that influence the risk of biochemical recurrence (BCR) in patients with localized PCa undergoing radical prostatectomy Materials and Methods: A total of 457 patients, operated by 2 surgeons in our high-volume oncological center were included in the initial database. Patients who underwent RP for clinically localized PCa in our clinic from 2016 to 2021 were included in the study. Perioperative data were retrospectively reviewed for this study. Follow-up data including post-operative PSA and adjuvant treatment was prospectively gathered by contacting the patients or from the follow-up consultation. Final database was composed of 366 patients who underwent open or 3D laparoscopic RP. Statistical analysis was performed to emphasize the most powerful parameters that influence the BCR.  Results: Accounting for multivariable analysis, 4 parameters were statistically significant: initial PSA (iPSA), Gleason score, vascular involvement and positive surgical margins. For the group of patients with no positive margins, 3 parameters were statistically significant: iPSA above 10,98 ng/mL (AUC=0,71); lymph node involvement and Gleason score. Multivariable Cox regression showed that positive margins and iPSA had a significant impact on the time to BCR. Patients that received adjuvant therapy were excluded from the study. Out of the whole cohort, 27,3% of patients presented BCR.</p><p><strong>Conclusion: </strong>Perioperative factors need to be carefully analyzed and a detailed follow-up needs to be conducted in order to assess the risk of biochemical recurrence, resulting in the optimal time for adjuvant treatment implementation.</p>","PeriodicalId":23416,"journal":{"name":"Urology Journal","volume":" ","pages":"162-168"},"PeriodicalIF":1.5,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139467071","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transplant Renal Artery Stenosis: A Case Report and Literature Review. 移植肾动脉狭窄:病例报告和文献综述。
IF 1.5 4区 医学 Q3 Medicine Pub Date : 2024-05-06 DOI: 10.22037/uj.v20i.7962
Nasser Simforoosh, Amirhossein Nayebzade, Meisam Ghaedi

Transplant renal artery stenosis is the most common vascular complication that occurs following kidney transplantation and can lead to graft dysfunction and even its loss. The present report describes A patient with endstage renal disease who underwent living related renal transplantation. He had oliguria and creatinine rise in the post-operative course but all doppler ultrasonography (DUS) during the 2 months post-operation for the renal graft showed a normal mean resistive index in the graft renal artery. Hemodialysis treatment started and continued for 4.5 months. On post-operative day 137, because of the patient's anuria and resistant hypertension, another DUS carried out and reported evidence that suggested arterial stenosis. A computed tomographic (CT) renal angiogram showed a small filling defect in the proximal graft artery that was highly suggestive for transplant renal artery stenosis (TRAS). Following angiography revealed a short linear stenosis. Endovascular intervention and stent placement were performed successfully for the patient on post-operative day 139. This case was initially diagnosed as ongoing acute rejection for which he received antirejection therapy without any significant improvement. After percutaneous transluminal angioplasty (PTA), serum creatinine trended down and urine output improved within 12 h, and they were stable at one-year follow up with a good renal function. It was noteworthy that, despite after a 4.5-month delay in diagnosis and maintenance need for dialysis, the patient responded to endovascular treatment and the graft function became normalized. Our case demonstrates that graft can be saved even if renal artery stenosis is diagnosed after several months of dialysis and diagnosis of end stage renal disease post transplantation.

移植肾动脉狭窄是肾移植术后最常见的血管并发症,可导致移植物功能障碍甚至丧失。本报告描述了一名接受活体肾移植的终末期肾病患者。他在术后出现少尿和血肌酐升高,但在术后 2 个月的肾移植多普勒超声(DUS)检查中,移植肾动脉的平均阻力指数显示正常。血液透析治疗开始并持续了 4.5 个月。术后第 137 天,由于患者出现无尿和抵抗性高血压,再次进行了 DUS 检查,结果显示动脉狭窄。计算机断层扫描(CT)肾血管造影显示近端移植动脉有一个小的充盈缺损,高度提示移植肾动脉狭窄(TRAS)。随后的血管造影显示出短线状狭窄。患者在术后第 139 天成功接受了血管内介入治疗和支架置入术。该病例最初被诊断为持续性急性排斥反应,接受了抗排斥治疗,但没有明显改善。经皮腔内血管成形术(PTA)后,12 小时内血清肌酐呈下降趋势,尿量也有所改善,随访一年后情况稳定,肾功能良好。值得注意的是,尽管诊断延迟了 4.5 个月,且需要透析维持,但患者对血管内治疗反应良好,移植物功能恢复正常。我们的病例表明,即使在透析数月后诊断出肾动脉狭窄,并在移植后诊断出终末期肾病,移植物仍可保存。
{"title":"Transplant Renal Artery Stenosis: A Case Report and Literature Review.","authors":"Nasser Simforoosh, Amirhossein Nayebzade, Meisam Ghaedi","doi":"10.22037/uj.v20i.7962","DOIUrl":"10.22037/uj.v20i.7962","url":null,"abstract":"<p><p>Transplant renal artery stenosis is the most common vascular complication that occurs following kidney transplantation and can lead to graft dysfunction and even its loss. The present report describes A patient with endstage renal disease who underwent living related renal transplantation. He had oliguria and creatinine rise in the post-operative course but all doppler ultrasonography (DUS) during the 2 months post-operation for the renal graft showed a normal mean resistive index in the graft renal artery. Hemodialysis treatment started and continued for 4.5 months. On post-operative day 137, because of the patient's anuria and resistant hypertension, another DUS carried out and reported evidence that suggested arterial stenosis. A computed tomographic (CT) renal angiogram showed a small filling defect in the proximal graft artery that was highly suggestive for transplant renal artery stenosis (TRAS). Following angiography revealed a short linear stenosis. Endovascular intervention and stent placement were performed successfully for the patient on post-operative day 139. This case was initially diagnosed as ongoing acute rejection for which he received antirejection therapy without any significant improvement. After percutaneous transluminal angioplasty (PTA), serum creatinine trended down and urine output improved within 12 h, and they were stable at one-year follow up with a good renal function. It was noteworthy that, despite after a 4.5-month delay in diagnosis and maintenance need for dialysis, the patient responded to endovascular treatment and the graft function became normalized. Our case demonstrates that graft can be saved even if renal artery stenosis is diagnosed after several months of dialysis and diagnosis of end stage renal disease post transplantation.</p>","PeriodicalId":23416,"journal":{"name":"Urology Journal","volume":" ","pages":"195-199"},"PeriodicalIF":1.5,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140140794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Urology Journal
全部 Appl. Geochem. Energy Ecol Environ Adv. Atmos. Sci. Adv. Meteorol. Ecol. Indic. ECOLOGY J. Afr. Earth. Sci. Atmos. Chem. Phys. Int. Geol. Rev. EUREKA: Physics and Engineering Int. J. Earth Sci. ARCT ANTARCT ALP RES Environ. Technol. Innovation Études Caribéennes Asia-Pac. J. Atmos. Sci. Eurasian Physical Technical Journal Appl. Phys. Rev. [Hokkaido igaku zasshi] The Hokkaido journal of medical science ENVIRONMENT Environ. Prog. Sustainable Energy Rev. Geophys. 2013 IEEE International Symposium on Hardware-Oriented Security and Trust (HOST) EVOL MED PUBLIC HLTH J. Atmos. Chem. Big Earth Data Aust. J. Earth Sci. Resour. Geol. J. Clim. 测绘科学技术 EUR PSYCHIAT Communications Earth & Environment ACTA GEOL SIN-ENGL Eurasian Journal of Emergency Medicine Environ. Chem. Environ. Geochem. Health ASTROBIOLOGY ECOSYSTEMS 2013 IEEE International Test Conference (ITC) 2009 International Conference on Energy and Environment Technology "Radiation and Risk" Bulletin of the National Radiation and Epidemiological Registry Appl. Clay Sci. IZV-PHYS SOLID EART+ ICHNOS Terra Nova Hydrol. Earth Syst. Sci. Nat. Hazards Earth Syst. Sci. J. Geog. Sci. Clim. Change Memai Heiko Igaku Expert Opin. Pharmacother. Mineral. Mag. Am. Mineral. Environmental Health Insights 非金属矿 Basin Res. ECOTOXICOLOGY ACTA GEOL POL J. Earth Sci. Contrib. Mineral. Petrol. Geostand. Geoanal. Res. ARCHAEOMETRY Conserv. Biol. Int. J. Biometeorol. Acta Geophys. Estudios Demográficos y Urbanos J. Hydrol. Org. Geochem. ATMOSPHERE-BASEL BIOGEOSCIENCES ENVIRON HEALTH-GLOB Atmos. Res. Acta Oceanolog. Sin. Environ. Prot. Eng. Archaeol. Anthropol. Sci. Carbon Balance Manage. Geosci. Front. Atmos. Meas. Tech. Conserv. Genet. Resour. Ann. Glaciol. Environ. Toxicol. Pharmacol. Geochim. Cosmochim. Acta Am. J. Phys. Anthropol. J. Atmos. Sol. Terr. Phys. Clean-Soil Air Water COMP BIOCHEM PHYS C Geophys. Prospect. J. Environ. Eng. Geophys. Geobiology Environ. Eng. Res. ACTA PETROL SIN 2009 2nd International Conference on Biomedical Engineering and Informatics GEOLOGY 2011 IEEE 2nd International Conference on Computing, Control and Industrial Engineering Environ. Pollut. Bioavailability GROUNDWATER Gondwana Res. Acta Geochimica Eur. J. Control Geochem. J. Chem. Ecol.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1